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INTRODUCTION
Project Extension for Community Healthcare 
Outcomes (ECHO) is an innovative means 
of expanding clinical providers’ knowledge 
and skills using virtual case- based learning in 
a ‘hub- and- spoke’ network of providers and 
specialists.1 Especially in rural and under-
served areas, where healthcare needs are 
great and access to care may be limited, ECHO 
presents a promising continuing education 
model and way to facilitate management of 
complex cases.2–5 It also provides clinicians 
with digital space for professional collabora-
tion and shared learning, which is valuable in 
today’s high- pressure practice environment6 
and can be rapidly deployed to address crises 
like the COVID-19 pandemic.7 However, 
some practitioners have argued that admin-
istrative demands on time, rather than access 
to specialty knowledge, are the barrier to 
developing networks of providers for mutual 
education.8 Other providers have noted that 
ECHO is likely not a ‘panacea for access to 
specialty care,’ but rather a ‘force multiplier’ 
for skills transfer.9 It, therefore, is important 
to capture and disseminate quality improve-
ment data to determine the ways in which 
ECHO programmes best can serve providers’ 
specialty healthcare training needs.
Our multidisciplinary team started an 
ECHO for opioid use disorder (OUD) in 
Indiana, USA, in 2018. Each session was 
hosted on Zoom and lasted 90 min; the first 
15 were a didactic presentation (eg, ‘Neuro-
biology of OUD and MAT’), and the latter 
75 were case- based learning, moderated by 
a panel of experts, focused on real, deiden-
tified cases submitted in advance by partici-
pants. Our ECHO programme has facilitated 
extensive participation in shared, case- based 
learning on OUD, producing more than 1771 
person- hours of attendance in the first year of 
operation alone, and has elucidated the need 
for statewide mentorship related to OUD and 
psychiatric comorbidities.10 However, not all 
participants became regular ECHO attenders, 
so we surveyed low- attendance participants 
for programmatic quality improvement. The 
results of this microstudy highlighted barriers 
to provider engagement in continuing educa-
tion and digital communities of practice.
METHODS
In 2018, we offered 2 OUD ECHO programmes 
for clinical providers, each consisting of 
12 weekly 90 min sessions. For this report, 
our population of interest was providers 
who attended at least one session of ECHO, 
attended fewer than the mean numbers of 
sessions attended (m=5.2 and 5.8, respec-
tively), and did not attend both programmes. 
The latter criterion was established prior 
to attendance review, and all but one dual- 
programme participant also attended more 
than five sessions. The total eligible popula-
tion was 21 providers (figure 1).
Invitations to participate in a brief evalu-
ation (five open- ended questions) hosted 
on Qualtrics were sent in three email waves; 
responses were incentivised by a US$20 
digital  Amazon. com gift card. The questions 
were informed by work by Salgia et al11 and 
White et al12 and were preceded with a state-
ment to reduce social desirability bias.13 The 
questionnaire was pilot tested with clinical 
providers (n=7) who were ineligible for the 
survey, including a mix of ECHO participants 
and team members. It was found to have 
face validity, except one question, which was 
adjusted for clarity prior to being fielded. All 
participants provided informed consent.
RESULTS
Of 21 eligible participants, 10 responded 
(47.6%) and 9 fully completed the survey 
(42.9%). Two authors reviewed and fully 
agreed on all major categorisations see 
(online supplemental file 1). Only questions 
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relevant to this topic were extracted for the short report. 
These were:
(1) In what ways did Indiana’s Opioid ECHO sessions 
not meet your expectations?
Two providers indicated the programme met their 
expectations. Among those whose expectations were not 
met, providers noted that scheduling or timing was diffi-
cult (n=3), or that the programme did not match their 
level of expertise (n=2), should not emphasise active 
participation (n=1) or permitted too much non- medical 
talk (n=1).
(2) Please tell us the primary reasons why you stopped 
attending the Indiana Opioid ECHO.
Most respondents identified timing and scheduling as 
the primary reason they stopped attending (n=8), with 
some adding that our attempt to make scheduling easier 
by holding the session around lunchtime had the oppo-
site effect (n=3). One respondent did not feel they had 
enough to add to the group.
(3) What changes, if any, could have been made to the 
Indiana Opioid ECHO that would have increased your 
likelihood of continuing to attend?
Most providers noted different or shorter periods of 
time (n=5) as the key change. Some (n=2, including one 
cross- code) preferred to watch videos of missed sessions. 
Others (n=3) shared unique recommendations, such as 
a group just for those ‘just beginning’ to manage OUD.
DISCUSSION
Infrequently attending Indiana OUD ECHO participants 
often were constrained by practical concerns (time/avail-
ability) rather than lack of interest or dissatisfaction with 
the ECHO model. This mirrors recent qualitative work 
indicating that external demands on time are a limiting 
factor for ECHO participation, though ECHO sessions 
were perceived as convenient and accessible.14 While 
accessing high- quality specialty education on Zoom is 
clearly more time- efficient than travelling to an academic 
medical centre, especially for rural providers, even 90 min 
sessions may not always be possible to attend.
Care should be taken with generalising results from 
this report, given the small sample size and single eval-
uation site. However, following this study, our team 
began to publicly release didactic notes for all sessions 
and more deliberately created topic- specific ‘tracks’ on 
different days of the week (eg, sessions on neonatal absti-
nence syndrome are Monday, sessions on adolescent SUD 
prevention are on Friday). It is not clear that these quality 
improvement efforts fully addressed the issues described 
by participants, especially in terms of session duration, 
but case- based learning is the core of ECHO and complex 
case management cannot easily be truncated.
We recommend that researchers study modified 
approaches (such as recorded sessions for asynchro-
nous learning) and upstream mechanisms of supporting 
ECHO participation (eg, policies or incentives for health-
care systems to support protected attendance time) for 
their potential to increase provider engagement. In 
the former case, however, it will be important to closely 
examine the degree to which case- based learning, a core 
facet of ECHO, can be achieved to a reasonable degree 
without synchronous interaction.
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Figure 1 Determination of sample. ECHO, Extension for Community Healthcare Outcomes.
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Table A. Exemplar quotes for results 
Question Category Exemplar(s) 
In what ways did Indiana’s Opioid 
ECHO sessions not meet your 
expectations? 
Timing/Scheduling “It was hard for me to get to all of them since 12N 
was over my lunch hour and sometimes I ran over 
seeing patients and couldn’t participate.” 
 
“Through no fault of their own, I have simply had a 
schedule change that has prevented me from 
attending more sessions.” 
 Didn’t Match 
Expertise 
“Sometimes, the expert inputs seemed a little 
simplistic.” 
 
“I didn’t feel like I benefited. I had no experience in 
treatment of opioid abuse.” 
 Other “Would prefer to be a passive participant but active 
participation is encouraged.” 
 
“Occasional non-medical, general time consuming 
talk.” 
Please tell us the primary reasons 
why you stopped attending the 
Indiana Opioid ECHO. 
Timing/Scheduling “My FT position started doing Wednesday weekly 
huddle meetings at the same time so I could no 
longer spend my lunch break tuning in.” 
 
“I just cannot block my schedule for the 90 min 
session at this point; however, I will continue to try 
to find a creative solution so that I can attend again. I 
really miss these.” 
 Other “I did not feel that I had enough knowledge to 
contribute to the group.” 
What changes, if any, could have 
been made to the Indiana Opioid 
ECHO that would have increased 





“When it is offered. For me, early morning or late 
afternoon would work better.” 
 





“If the meetings could be archived so I could watch 
later in case I couldn’t attend that day.” 
 
“Different times [cross-coded with above] or 
recorded sessions to tune in and watch later.” 
 Other “Maybe a group for those just beginning and wanting 
to learn more about management of opioid abuse.” 
 
“Review of pharmacology of medications at each 
meeting, brief synopsis, and any change in 
guidelines.” 
 
“Patient specific treatment presentations are useful; 
treating methamphetamine addiction is a huge issue: 
no suboxone equivalent for meth, it’s behavioral and 
prevalent; difficulty obtaining psychiatric referrals 
for many psychiatric co-morbid disorders; no 
psychiatrists available in [Redacted].” 
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